Status:
WITHDRAWN
Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges: Pilot Phase
Lead Sponsor:
RAND
Collaborating Sponsors:
Northwestern University
University of California, Los Angeles
Conditions:
Fall
Congestive Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Polypharmacy is common among older adults in the United States and is associated with harms such as adverse drug reactions and higher costs of care. This pilot-phase project is designed to test two el...
Detailed Description
Polypharmacy increases the likelihood of being prescribed and harmed by high-risk medications. As noted in the 2014 National Action Plan for Adverse Drug Event (ADE) Prevention, polypharmacy both incr...
Eligibility Criteria
Inclusion
- Primary care clinicians practicing in one of the participating Northwestern-affiliated practices
Exclusion
- none
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03791580
Start Date
February 1 2019
End Date
September 1 2019
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Medicine
Chicago, Illinois, United States, 60611